D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 22.58 CNY -0.79%
Updated: May 17, 2024

DaShenLin Pharmaceutical Group Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DaShenLin Pharmaceutical Group Co Ltd
Revenue Peer Comparison

Comparables:
603883
605266
603939
301017
002727

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Revenue
¥25.3B
CAGR 3-Years
18%
CAGR 5-Years
22%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Revenue
¥22.5B
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
Revenue
¥7.5B
CAGR 3-Years
29%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Revenue
¥23.3B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Revenue
¥9.2B
CAGR 3-Years
26%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Revenue
¥18B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is DaShenLin Pharmaceutical Group Co Ltd's Revenue?
Revenue
25.3B CNY

Based on the financial report for Mar 31, 2024, DaShenLin Pharmaceutical Group Co Ltd's Revenue amounts to 25.3B CNY.

What is DaShenLin Pharmaceutical Group Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
22%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for DaShenLin Pharmaceutical Group Co Ltd have been 18% over the past three years , 22% over the past five years .